The CTI Exchange's resource library offers information about contraceptive research and development, regulatory requirements, quality assurance, product introduction, and advocacy


0 results found


The Family Planning and Reproductive Health Indicators Database, housed on the Data for Impact website, provides a comprehensive listing of the most widely used indicators for evaluating family planning and reproductive health programs in developing countries. The database contains definitions, data requirements, data sources, purposes, and issues for core indicators along with links to other websites and documents containing additional family planning and reproductive health indicators.

Family Planning and Reproductive Health (FP/RH) Indicators Database

The LactMed® database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. It includes information on the levels of such substances in breast milk and infant blood, and the possible adverse effects in the nursing infant. Suggested therapeutic alternatives to those drugs are provided, where appropriate.

Drugs and Lactation Database (LactMed)

This database, funded by funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, is a curation of public databases for the purpose of providing a list of human reproductive system/tissue specific contraceptive targets for investigators working in the field. The goal of CITDBase is not only to identity potential contraceptive targets but, equally important, to foster collaborative efforts between the investigators from different areas of contraceptive and infertility research.

NICHD Contraceptive Infertility Target Database (CITDBase)

This report from Policy Cures Research presents the diverse sexual and reproductive health (SRH) R&D funding landscape and highlights a broad spectrum of investment in 2018, totaling $1.7 billion. Based on responses from governments, non-profits, foundations and industry, the 2020 G-FINDER SRH report provides the most up-to-date comprehensive look at the R&D landscape for SRH health issues that disproportionately affect people in low- and middle-income countries (LMICs).

G-FINDER Sexual and Reproductive Health Report 2020

A podcast from Male Contraceptive Initiative, produced by Logan Nickels and Kevin Shane. Intended asks the question – If nearly half of all pregnancies are still unintended, why don’t we have more male birth control options? Unraveled over the course of 8 parts, Intended brings scientists, historians, and couples together to understand the life of The Pill for men in an immersive audio exploration.

"Intended" podcast by Male Contraceptive Initiative (MCI)

This interactive tool provides an innnovative model for estimating impact of removing injectables from the contraceptive method mix.

Planning for Outcomes (P4O)

The American Society for Reproductive Medicine (ASRM) is a non-profit organization whose members must demonstrate the high ethical principles of the medical profession, evince an interest in infertility, reproductive medicine and biology, and adhere to the objectives of the Society. ASRM's vision is to be the nationally and internationally recognized leader for multidisciplinary information, education, advocacy and standards in the field of reproductive medicine.

American Society for Reproductive Medicine (ASRM)

The Association of Clinical Research Professionals (ACRP) supports clinical research professionals through membership, training and development, and certification. Founded in 1976, ACRP is a US-based non-profit organization with more than 13,000 members who work in clinical research in more than 70 countries.

Association of Clinical Research Professionals (ACRP)

The Endocrine Society is an organization devoted to research on hormones and the clinical practice of endocrinology. It is an international body whose membership represents medicine, molecular and cellular biology, biochemistry, physiology, genetics, immunology, education, industry, and allied health fields.

Endocrine Society

The mission of the Society for Reproductive Investigation (SRI) is to advance reproductive and women's health care through outstanding basic, translational, and clinical science and by training and mentoring future generations of investigators. SRI members conduct basic, translational and clinical investigation in the reproductive sciences and women’s health. Areas of focus included obstetrics, perinatology, reproductive genetics, gynecology and more.

Society for Reproductive Investigation (SRI)

The Society for the Study of Reproduction (SSR) promotes the study of reproduction by fostering interdisciplinary communication among scientists, holding conferences, and publishing meritorious studies. The SSR is an association of scientists and physicians, from 50 countries around the world, interested in research on reproduction.

Society for the Study of Reproduction (SSR)

The Association of University Technology Managers (AUTM) works to support and advance academic technology transfers. AUTM members are individuals and organizations involved in all aspects of protecting, licensing and managing academic intellectual property.

Association of University Technology Managers (AUTM)

The RePORT (Research Portfolio Online Reporting Tools) website provides access to a variety of reporting tools, reports, data, and analyses of research activities sponsored by the National Institutes of Health (NIH). One of the tools available is the RePORTER (RePORT Expenditures and Results) module, an electronic tool that allows users to search a repository of NIH-funded research projects and access publications and patents resulting from NIH funding.

Research Portfolio Online Reporting Tools (RePORT)

This tool from the Global Health Network was created to enable equity in access to research opportunities. Through this platform, research sites (and potential research sites!) can register and let would-be collaborators and sponsors know about them, their previous experience and what type of research they would like to take part in.


This site includes links to a number of databases from the U.S. FDA including the Dissoluation Methods database, the Electronic Orange Book with information about approved generic drugs, and a database of inactive ingredients

U.S. FDA Drug Approvals And Databases

This platform, operated by WHO, aims to ensure that a complete view of research is accessible to all those involved in health care decision making. This will improve research transparency and will ultimately strengthen the validity and value of the scientific evidence base.

WHO International Clinical Trials Registry Platform

This framework, developed by TDR and the Global Health Network, lists the competencies that should be demonstrated by the research team as a whole to carry out a successful clinical study. This flexible framework can be applied to any clinical research study, regardless of the size of the team, place, disease focus and type of research. Together with its supporting tools, the framework can be used to: plan staffing requirements for a study, carry out appraisals of staff, and create educational curricula for research staff.

Global Competency Framework for Clinical Research

This report from the Guttmacher Institute explores the need for new investments in contraceptive research and development, with a focus towards new contraceptive methods that do not cause systemic side effects, can be used on-demand, and do not require partner participation or knowledge.

Contraceptive Technologies: Responding to Women's Needs

The Contraceptive Technology Innovation Lab leverages Human Centered Design to facilitate insight-driven ideation for future contraceptive technologies, anchored in women's needs. This website includes results from ideation events in Kenya and India in 2018.

Contraceptive Technology Innovation Lab

This report, issued by the Institute of Medicine, identifies priority areas for research to develop new contraceptives. It highlights new technologies and approaches to biomedical research, including genomics and proteomics, that hold particular promise for developing new products and also identifies impediments to drug development that must be addressed.

New Frontiers in Contraceptive Research: A Blueprint for Action

no results found